{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:13:10Z","timestamp":1794366790032,"version":"4.9.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104884","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:01:42Z","timestamp":1596308502000},"page":"104884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening"],"prefix":"10.1016","volume":"182","author":[{"given":"Zhe-Rui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104884_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.11.015","article-title":"Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus","volume":"137","author":"Balasubramanian","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsinfecdis.5b00070","article-title":"Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase","volume":"1","author":"Brecher","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104884_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/v6010013","article-title":"Replication cycle and molecular biology of the West Nile virus","volume":"6","author":"Brinton","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104884_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1959.8.651","article-title":"Ecologic studies of Japanese encephalitis virus in Japan. II. Mosquito infection","volume":"8","author":"Buescher","year":"1959","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2020.104884_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2020.104884_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","volume":"13","author":"de Freitas","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104884_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/v8070181","article-title":"Development of neutralization assay using an eGFP chikungunya virus","volume":"8","author":"Deng","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104884_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007681","article-title":"Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti","volume":"13","author":"Dong","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104884_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0749-0739(17)30096-2","article-title":"Japanese encephalitis","volume":"16","author":"Ellis","year":"2000","journal-title":"Vet. Clin. N. Am. Equine Pract."},{"key":"10.1016\/j.antiviral.2020.104884_bib11","doi-asserted-by":"crossref","first-page":"34550","DOI":"10.1038\/srep34550","article-title":"Structure-based discovery of two antiviral inhibitors targeting the NS3 helicase of Japanese encephalitis virus","volume":"6","author":"Fang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104884_bib12","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/trf.13729","article-title":"Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light","volume":"56","author":"Fryk","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.antiviral.2020.104884_bib13","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/trf.14256","article-title":"Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light","volume":"57","author":"Fryk","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.antiviral.2020.104884_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/cbdd.13091","article-title":"Sofosbuvir as treatment against dengue?","volume":"91","author":"Gan","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2020.104884_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/B978-0-444-53488-0.00026-2","article-title":"Japanese encephalitis virus infection","volume":"123","author":"Griffiths","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.antiviral.2020.104884_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbrc.2016.12.081","article-title":"Inhibition of Japanese encephalitis virus (JEV) replication by specific RNA aptamer against JEV methyltransferase","volume":"483","author":"Han","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104884_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese encephalitis in travelers from non-endemic countries, 1973-2008","volume":"82","author":"Hills","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2020.104884_bib18","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1473-3099(15)00074-2","article-title":"Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial","volume":"15","author":"Koh","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104884_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2017.12.017","article-title":"Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus","volume":"150","author":"Li","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2020.104884_bib22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/vir.0.061838-0","article-title":"Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A","volume":"95","author":"Li","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/vir.0.061838-0","article-title":"Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A","volume":"95","author":"Li","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7150\/thno.16615","article-title":"Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.antiviral.2020.104884_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/v4030397","article-title":"Innate immunity evasion by Dengue virus","volume":"4","author":"Morrison","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104884_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrmicro1928","article-title":"Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis","volume":"6","author":"Murray","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104884_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003610","article-title":"RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication","volume":"9","author":"Nikonov","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104884_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2005.07.001","article-title":"Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo","volume":"68","author":"Papin","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib30","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1099\/vir.0.000097","article-title":"Post-translational regulation and modifications of flavivirus structural proteins","volume":"96","author":"Roby","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib31","article-title":"SARS-CoV-2 and SARS-CoV: virtual Screening of Potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12)","author":"Ruan","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib33","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1073\/pnas.1212379109","article-title":"Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro","volume":"109","author":"Schoggins","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104884_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000321483","article-title":"Mycophenolic acid inhibits replication of Japanese encephalitis virus","volume":"57","author":"Sebastian","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.antiviral.2020.104884_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12918-017-0518-x","article-title":"Dengue virus causes changes of MicroRNA-genes regulatory network revealing potential targets for antiviral drugs","volume":"12","author":"Shahen","year":"2018","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.antiviral.2020.104884_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.antiviral.2012.12.010","article-title":"Development and characterization of a stable eGFP enterovirus 71 for antiviral screening","volume":"97","author":"Shang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.1251249","article-title":"Structural biology. Unraveling a flavivirus enigma","volume":"343","author":"Shi","year":"2014","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2020.104884_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/jiu377","article-title":"Repurposing of prochlorperazine for use against dengue virus infection","volume":"211","author":"Simanjuntak","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104884_bib39","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1128\/JVI.00525-12","article-title":"Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A","volume":"86","author":"Tu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/21645515.2017.1380756","article-title":"Risk assessment for Japanese encephalitis vaccination","volume":"14","author":"Turtle","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2020.104884_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13046-018-0904-2","article-title":"Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells","volume":"37","author":"Veschi","year":"2018","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01055-17","article-title":"Screening of FDA-approved drugs for inhibitors of Japanese encephalitis virus infection","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib43","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104884_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2020.104884_bib45","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00705-017-3508-9","article-title":"Development of a stable Japanese encephalitis virus replicon cell line for antiviral screening","volume":"162","author":"Zhang","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104884_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2011.05.001","article-title":"Development and characterization of a stable luciferase dengue virus for high-throughput screening","volume":"91","author":"Zou","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104884_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2014.01.011","article-title":"Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III","volume":"104","author":"Zu","year":"2014","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:34:46Z","timestamp":1759062886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":47,"alternative-id":["S0166354220302989"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104884","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738438244.793577459","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104884"}}